Toxoplasma Effector Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block IFN-γ-Dependent Gene Expression

Cell Host and Microbe

Volumn 20, Issue 1, 2016, Pages 72-82

  Olias, Philipp ^a   Etheridge, Ronald D ^a   Zhang, Yong ^a   Holtzman, Michael J ^a   Sibley, L David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acetylation; nuclear transport; phosphorylation; signaling; transcription

Indexed keywords

GAMMA INTERFERON; HISTONE DEACETYLASE; STAT1 PROTEIN; IFNG PROTEIN, MOUSE; PROTOZOAL PROTEIN; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE GENE; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOSOME; PARASITE CLEARANCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROMOTER REGION; SECRETORY GRANULE; TOXOPLASMA GONDII; VIRUS PATHOGENESIS; ANIMAL; ANTAGONISTS AND INHIBITORS; GENE DELETION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TOXOPLASMA;

ANIMALS; GENE DELETION; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; INTERFERON-GAMMA; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; PROTOZOAN PROTEINS; STAT1 TRANSCRIPTION FACTOR; TOXOPLASMA; TRANSCRIPTION, GENETIC;

EID: 84991069511     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2016.06.006     Document Type: Article

References (45)

1. Beiting, D.P., Hidano, S., Baggs, J.E., Geskes, J.M., Fang, Q., Wherry, E.J., Hunter, C.A., Roos, D.S., Cherry, S., The orphan nuclear receptor TLX is an enhancer of STAT1-mediated transcription and immunity to Toxoplasma gondii. PLoS Biol., 13, 2015, e1002200.
2. Bougdour, A., Durandau, E., Brenier-Pinchart, M.P., Ortet, P., Barakat, M., Kieffer, S., Curt-Varesano, A., Curt-Bertini, R.L., Bastien, O., Coute, Y., et al. Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 13 (2013), 489–500.
3. Bowen, N.J., Fujita, N., Kajita, M., Wade, P.A., Mi-2/NuRD: multiple complexes for many purposes. Biochim. Biophys. Acta 1677 (2004), 52–57.
4. Braun, L., Brenier-Pinchart, M.P., Yogavel, M., Curt-Varesano, A., Curt-Bertini, R.L., Hussain, T., Kieffer-Jaquinod, S., Coute, Y., Pelloux, H., Tardieux, I., et al. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J. Exp. Med. 210 (2013), 2071–2086.
5. Cismasiu, V.B., Paskaleva, E., Suman Daya, S., Canki, M., Duus, K., Avram, D., BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 380 (2008), 173–181.
6. Curt-Varesano, A., Braun, L., Ranquet, C., Hakimi, M.A., Bougdour, A., The aspartyl protease TgASP5 mediates the export of the Toxoplasma GRA16 and GRA24 effectors into host cells. Cell. Microbiol. 18 (2016), 151–167.
7. Darnell, J.E. Jr., Kerr, I.M., Stark, G.R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994), 1415–1421.
8. Deckert-Schlüter, M., Rang, A., Weiner, D., Huang, S., Wiestler, O.D., Hof, H., Schlüter, D., Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 75 (1996), 827–841.
9. Dembowski, J.A., DeLuca, N.A., Selective recruitment of nuclear factors to productively replicating herpes simplex virus genomes. PLoS Pathog., 11, 2015, e1004939.
10. Denslow, S.A., Wade, P.A., The human Mi-2/NuRD complex and gene regulation. Oncogene 26 (2007), 5433–5438.
11. Franco, M., Panas, M.W., Marino, N.D., Lee, M.C., Buchholz, K.R., Kelly, F.D., Bednarski, J.J., Sleckman, B.P., Pourmand, N., Boothroyd, J.C., A novel secreted protein, MYR1, is central to Toxoplasma's manipulation of host cells. MBio, 7, 2016 e02231–e15.
12. Gavrilescu, L.C., Butcher, B.A., Del Rio, L., Taylor, G.A., Denkers, E.Y., STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect. Immun. 72 (2004), 1257–1264.
13. Gazzinelli, R.T., Wysocka, M., Hayashi, S., Denkers, E.Y., Hieny, S., Caspar, P., Trinchieri, G., Sher, A., Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153 (1994), 2533–2543.
14. Hammoudi, P.M., Jacot, D., Mueller, C., Di Cristina, M., Dogga, S.K., Marq, J.B., Romano, J., Tosetti, N., Dubrot, J., Emre, Y., et al. Fundamental roles of the Golgi-associated Toxoplasma aspartyl protease, ASP5, at the host-parasite interface. PLoS Pathog., 11, 2015, e1005211.
15. Hsiao, C.H., Luisa Hiller, N., Haldar, K., Knoll, L.J., A HT/PEXEL motif in Toxoplasma dense granule proteins is a signal for protein cleavage but not export into the host cell. Traffic 14 (2013), 519–531.
16. Hunter, C.A., Sibley, L.D., Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10 (2012), 766–778.
17. Kim, S.K., Fouts, A.E., Boothroyd, J.C., Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J. Immunol. 178 (2007), 5154–5165.
18. Kim, B.H., Shenoy, A.R., Kumar, P., Bradfield, C.J., MacMicking, J.D., IFN-inducible GTPases in host cell defense. Cell Host Microbe 12 (2012), 432–444.
19. Lang, C., Hildebrandt, A., Brand, F., Opitz, L., Dihazi, H., Lüder, C.G., Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ. PLoS Pathog., 8, 2012, e1002483.
20. Lieberman, L.A., Banica, M., Reiner, S.L., Hunter, C.A., STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J. Immunol. 172 (2004), 457–463.
21. Lüder, C.G.K., Lang, T., Beuerle, B., Gross, U., Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112 (1998), 308–316.
22. Lüder, C.G., Walter, W., Beuerle, B., Maeurer, M.J., Gross, U., Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur. J. Immunol. 31 (2001), 1475–1484.
23. Lüder, C.G., Algner, M., Lang, C., Bleicher, N., Gross, U., Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Int. J. Parasitol. 33 (2003), 833–844.
24. Majumder, K., Koues, O.I., Chan, E.A., Kyle, K.E., Horowitz, J.E., Yang-Iott, K., Bassing, C.H., Taniuchi, I., Krangel, M.S., Oltz, E.M., Lineage-specific compaction of Tcrb requires a chromatin barrier to protect the function of a long-range tethering element. J. Exp. Med. 212 (2015), 107–120.
25. Najjar, I., Fagard, R., STAT1 and pathogens, not a friendly relationship. Biochimie 92 (2010), 425–444.
26. Nathan, C.F., Murray, H.W., Wiebe, M.E., Rubin, B.Y., Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158 (1983), 670–689.
27. Ni, Z., Karaskov, E., Yu, T., Callaghan, S.M., Der, S., Park, D.S., Xu, Z., Pattenden, S.G., Bremner, R., Apical role for BRG1 in cytokine-induced promoter assembly. Proc. Natl. Acad. Sci. USA 102 (2005), 14611–14616.
28. Pfefferkorn, E.R., Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81 (1984), 908–912.
29. Ramana, C.V., Chatterjee-Kishore, M., Nguyen, H., Stark, G.R., Complex roles of Stat1 in regulating gene expression. Oncogene 19 (2000), 2619–2627.
30. Reich, N.C., Liu, L., Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6 (2006), 602–612.
31. Rosowski, E.E., Saeij, J.P., Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ induced gene expression and STAT1 phosphorylation. PLoS ONE, 7, 2012, e51448.
32. Rosowski, E.E., Nguyen, Q.P., Camejo, A., Spooner, E., Saeij, J.P., Toxoplasma gondii inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA. Infect. Immun. 82 (2014), 706–719.
33. Schindler, C., Darnell, J.E. Jr., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64 (1995), 621–651.
34. Schneider, A.G., Abi Abdallah, D.S., Butcher, B.A., Denkers, E.Y., Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activity. PLoS ONE, 8, 2013, e60215.
35. Shen, B., Brown, K.M., Lee, T.D., Sibley, L.D., Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. MBio, 5, 2014 e01114–e14.
36. Shuai, K., Stark, G.R., Kerr, I.M., Darnell, J.E. Jr., A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261 (1993), 1744–1746.
37. Silmon de Monerri, N.C., Kim, K., Pathogens hijack the epigenome: a new twist on host-pathogen interactions. Am. J. Pathol. 184 (2014), 897–911.
38. Stark, G.R., Darnell, J.E. Jr., The JAK-STAT pathway at twenty. Immunity 36 (2012), 503–514.
39. Stuehr, D.J., Gross, S.S., Sakuma, I., Levi, R., Nathan, C.F., Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169 (1989), 1011–1020.
40. Suzuki, Y., Conley, F.K., Remington, J.S., Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143 (1989), 2045–2050.
41. Taylor, G.A., Feng, C.G., Sher, A., Control of IFN-gamma-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases). Microbes Infect. 9 (2007), 1644–1651.
42. Terhune, S.S., Moorman, N.J., Cristea, I.M., Savaryn, J.P., Cuevas-Bennett, C., Rout, M.P., Chait, B.T., Shenk, T., Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. PLoS Pathog., 6, 2010, e1000965.
43. Yap, G.S., Sher, A., Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189 (1999), 1083–1092.
44. Zhang, Y., Takami, K., Lo, M.S., Huang, G., Yu, Q., Roswit, W.T., Holtzman, M.J., Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J. Biol. Chem. 280 (2005), 34306–34315.
45. Zhang, Y., Mao, D., Roswit, W.T., Jin, X., Patel, A.C., Patel, D.A., Agapov, E., Wang, Z., Tidwell, R.M., Atkinson, J.J., et al. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat. Immunol. 16 (2015), 1215–1227.